Zhongshan Yang

Kunming, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Correction: Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

Correction: Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

Journal: Frontiers in immunology

Published: July 17, 2026

Total Saponins of Panax Notoginseng Leaves Modulate the "Microglial-NLRP3/Caspase-1" Axis associated with Gut Microbial/SCFAs Alterations: Correlative Insights into Cognitive Improvement in Senescence.

Total Saponins of Panax Notoginseng Leaves Modulate the "Microglial-NLRP3/Caspase-1" Axis associated with Gut Microbial/SCFAs Alterations: Correlative Insights into Cognitive Improvement in Senescence.

Journal: Molecular neurobiology

Published: April 09, 2026

Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

Journal: Frontiers in immunology

Published: December 25, 2025

Huanglian muxiang decoction alleviates FTH-mediated ferroptosis in colitis by inhibiting the PI3K-AKT pathway.

Huanglian muxiang decoction alleviates FTH-mediated ferroptosis in colitis by inhibiting the PI3K-AKT pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 14, 2025

Berberine as an Antimicrobial Agent and Gut Microbiota Modulator: Mechanisms and Therapeutic Potential.

Berberine as an Antimicrobial Agent and Gut Microbiota Modulator: Mechanisms and Therapeutic Potential.

Journal: Current medicinal chemistry

Published: September 22, 2025

Gut microbiota-dependent anti-inflammatory mechanisms of berberine in ameliorating hypertension: role of SCFAs, LPS reduction, and STAT3 signaling.

Gut microbiota-dependent anti-inflammatory mechanisms of berberine in ameliorating hypertension: role of SCFAs, LPS reduction, and STAT3 signaling.

Journal: Frontiers in pharmacology

Published: September 01, 2025

Lipotoxicity: A New Perspective in Type 2 Diabetes Mellitus.

Lipotoxicity: A New Perspective in Type 2 Diabetes Mellitus.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: December 19, 2024

Tryptophan Indole Derivatives: Key Players in Type 2 Diabetes Mellitus.

Tryptophan Indole Derivatives: Key Players in Type 2 Diabetes Mellitus.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: December 18, 2024

Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes.

Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes.

Journal: Neural regeneration research

Published: December 10, 2024

Vasoactive Intestinal Peptide: A Neuropeptide that Plays an Important Role in Parkinson's Disease.

Vasoactive Intestinal Peptide: A Neuropeptide that Plays an Important Role in Parkinson's Disease.

Journal: Current neuropharmacology

Published: November 28, 2024

Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson's disease mouse model.

Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson's disease mouse model.

Journal: Journal of drug targeting

Published: February 05, 2024

The influence of the gut microbiota on B cells in autoimmune diseases.

The influence of the gut microbiota on B cells in autoimmune diseases.

Journal: Molecular medicine (Cambridge, Mass.)

Published: November 07, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026